Clinical Pharmacy and Pharmacotherapy
Clinical Pharmacy and Pharmacotherapy tests patient-specific drug selection, dosing, monitoring, and pharmaceutical care. Questions commonly present a clinical scenario requiring integration of renal function, comorbidities, interactions, and evidence-based guidelines.
Core rules
- Assessment covers indication, effectiveness, safety, adherence, and patient preferences. Dose adjustment uses Cockcroft–Gault creatinine clearance for many renally cleared drugs; eGFR is not interchangeable in every drug label.
- Loading doses are usually unchanged in renal impairment; maintenance doses are reduced.
- Therapeutic drug monitoring is useful for narrow-index drugs with poor concentration–effect correlation: vancomycin, aminoglycosides, digoxin, lithium, and phenytoin.
- Pharmacovigilance requires identifying adverse drug reactions, assessing causality, documenting, and reporting serious reactions.
Worked example
An older patient with creatinine clearance 25 mL/min is prescribed gentamicin. Reasoning: gentamicin is renally eliminated and nephrotoxic and ototoxic. Do not simply use the standard interval; extend the interval and monitor trough concentrations, renal function, and hearing. If an alternative exists, choose it. A loading dose may still be needed to achieve therapeutic concentrations quickly.
Traps
Using serum creatinine alone without age or weight; reducing a loading dose unnecessarily; assuming all renal dosing applies to every indication; missing drug–disease interactions such as NSAIDs in heart failure.